Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial

Faster, Cleaner, Better.

Ultra Nasdaq Biotechnology 2X ETF (BIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

ETF Comparison for [[ item.sessionDateDisplayLong ]]

Results

Want to compare other data? Select Fields

Symbol	BIB
Company	Ultra Nasdaq Biotechnology 2X ETF
Price Information
Exchange	NASDAQ
Open	85.20
High	85.20
Low	81.22
Latest	81.57
Change	-2.80
% Change	-3.32%
Volume	11,700
20-Day Average Volume	10,130
Previous Close	84.36
Industry	N/A
Has Options	Yes
Technicals
20-Day Moving Average	79.12
20-Day Raw Stochastic	68.18%
20-Day Relative Strength	50.46
Weighted Alpha	+89.59
Today's Opinion	32% Buy
Previous Opinion	64% Buy
Last Month's Opinion	56% Buy
Performance
5-Days
%Chg	-0.25% since 04/02/26
Low	78.35 on 04/07/26
High	85.20 on 04/10/26
1-Month
%Chg	-4.07% since 03/10/26
Low	73.78 on 03/27/26
High	85.34 on 03/11/26
3-Month
%Chg	-1.28% since 01/09/26
Low	73.78 on 03/27/26
High	90.90 on 02/25/26
6-Month
%Chg	+27.78% since 10/10/25
Low	62.72 on 10/14/25
High	90.90 on 02/25/26
Key Statistics
Market Capitalization, $K	79,119
Shares Outstanding, K	970
Annual Sales	0
Annual Net Income	0
Last Quarter Sales	N/A
Last Quarter Net Income	N/A
60-Month Beta	1.35
Per-Share Information
Most Recent Earnings	N/A
Latest Earnings Date	06/27/14
Most Recent Dividend	0.007 on 03/25/26
Next Ex-Dividends Date	03/25/26
Ratios
Price/Earnings ttm	0.00